Continuing with the month’s gout mini-theme, Takeda Pharmaceutical Co. (T: 4502) is acquiring URL Pharma, which manufactures Colcrys, a treatment for gout flare-ups. Out of URL’s nearly $600.0 million in annual revenue, Colcrys generated $430.0 million. Takeda is...
Brought to you by www.DealSearchOnline.com June 4, 2012 Issue: Recent Health Care M&A Deals The Premiums They Paid, Part I- A New Series Explores Premiums In Health Care M&A Spotlight on: E-Health Conference Calendar Recent Health Care M&A...
A New Series Explores Premiums In Health Care M&A This month we inaugurate a series of articles on the premiums that are paid in health care acquisitions and takeovers. The premium/discount is the amount by which the purchase price exceeds/falls below the...
Brought to you by www.DealSearchOnline.com May 29, 2012 Issue: Recent Health Care M&A Deals Spotlight on: Biotechnology Spotlight on: Medical Devices Conference Calendar Recent Health Care M&A Deals BIOTECHNOLOGY Acquirer Target Price Vidara...
In the largest Medical Device deal for April, Hologic (NASDAQ: HOLX), a company focused on diagnostic and medical imaging systems, is acquiring Gen-Probe (NASDAQ: GPRO) for $3.72 billion. Based in San Diego, GPRO develops, manufactures and markets molecular diagnostic...
In April’s largest Biotechnology deal, the British-Swedish pharmaceutical company AstraZeneca plc (NYSE: AZN) is acquiring Ardea Biosciences (NASDAQ: RDEA), a biotech that is focused on the discovery and development of small-molecule therapeutics treating gout and...